शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEJeevan Scientific Technology L· Healthcare ServicesHighNeutral
Announced Thu, 13 Aug, 2026 · 15:15 IST

Board Meeting Outcome: Director Re-appointments and Q1 FY27 Results

Promoter Family Board EntryManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+6.3%Reaction day
₹78.51
prior close
₹82.80
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+6.1% vs market
Healthcare Services peers, median of 61sector · industry level-0.2%+6.5% vs sector

On the reaction day the stock moved 6.1 pts more than Nifty Microcap 250 and 6.5 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
+0.8
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+6.3+0.2+6.1-0.2+6.5
Next day
+2.0+0.2+1.8-1.2+3.2
2d
-0.7+0.4-1.0-0.8+0.1
3d
-3.2+0.7-3.9-0.9-2.3
4d
-5.0+0.1-5.1-1.4-3.5
5d
-5.7+0.7-6.4-0.9-4.8
1w
-5.7+1.2-6.9-1.1-4.7
15d
-3.5+0.7-4.3-0.9-2.6
1m
+3.2-1.2+4.4-0.8+4.0
2m
+5.1-1.1+6.2-8.1+13.2
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 61Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 results: standalone revenue Rs 1,693.47 lakhs (up from Rs 821.57 lakhs YoY), net profit Rs 188.60 lakhs versus a loss of Rs 215.99 lakhs YoY. Re-appointed Mrs. Snigdha Mothukuri and Mr. Nageswar Rao Yarllagadda as Whole Time Directors. Appointed Mr. Kolli Srinivas Rao as new Independent Director for 5 years. AGM scheduled for 25 September 2026.

Likely market impact

Strong Q1 turnaround with revenue more than doubling and swing to profit. Board re-appointments maintain continuity with one new Independent Director added.